Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients

Eur Heart J. 2014 Mar;35(9):563-70. doi: 10.1093/eurheartj/eht539. Epub 2013 Dec 15.

Abstract

Aims: Current guidelines recommend early referral and initiation of intensive cardiovascular (CV) risk reduction in individuals with a positive family history of coronary heart disease (CHD). We hypothesized that a family history of premature CHD and stroke [CV disease (CVD)] would lead to earlier referral of hypertensive patients to secondary care clinic, leading to better control of risk factors, mitigating the excess risk seen in these individuals.

Methods and results: We studied the association of a positive family history of CVD in 10 787 individuals with longitudinal changes in risk factors and long-term cause-specific mortality in the Glasgow Blood Pressure Clinic using generalized estimating equations and the Cox proportional hazard models, respectively. The total time at risk was 193 756 person-years with a median survival time of 29.2 years. A positive family history of CVD was associated with an earlier presentation to the clinic, a lower burden of traditional CV risk factors, and similar longitudinal blood pressure reduction and drug adherence compared with those without. But despite these positive features, all-cause [hazard ratio (HR) = 1.12, 95% confidence interval 1.01-1.25] and CV (HR = 1.20, 1.04-1.38) mortality independent of baseline risk factors were worse. Consistent results were observed in propensity score-matched analysis. Inclusion of family history of CVD did not improve mortality risk discrimination over and above traditional risk factors.

Conclusion: Our study suggests that despite earlier referral and treatment of individuals with a positive family history of premature CVD, excess risk persists, indicating the need for continued and sustained efforts to reduce risk factors and drug adherence in these individuals.

Keywords: Epidemiology; Family history; Hypertension; Mortality.

Publication types

  • Observational Study

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / physiology
  • Female
  • Glomerular Filtration Rate / physiology
  • Humans
  • Hypertension / genetics*
  • Hypertension / mortality
  • Hypertension / prevention & control
  • Male
  • Medication Adherence
  • Middle Aged
  • Pedigree
  • Prognosis
  • Propensity Score
  • Risk Factors
  • Scotland / epidemiology

Substances

  • Antihypertensive Agents